Breast Cancer Clinical Trial
Chemotherapy-Induced Peripheral Neuropathy-Essential Oil Intervention
Summary
This study will evaluate an oil blend with active ingredients for the reduction in chemotherapy-induced peripheral neuropathy in people with breast cancer. Half of the participants will receive the oil blend with active ingredients and the other half will receive a placebo (an oil blend with no active ingredients). One-fourth of the people will also take pictures of their life with chemotherapy-induced peripheral neuropathy.
Full Description
Chemotherapy-induced peripheral neuropathy (CIPN) is a painful, debilitating consequence of cancer treatment and is considered the most adverse of non-hematologic events. Current pharmacological approaches to reduce CIPN symptoms can be ineffective and cause adverse effects.
Constituents of this oil blend moderate pain signal transmission through non-competing inhibition of 5-HT, AchE, and Substance P, along with antagonism of TRPA1 and TRPV1. This study will test the hypothesis that an oil blend reduces CIPN symptoms and improves quality-of-life (QOL) in breast cancer patients. The Human Response to Illness model is used to underpin a convergent-nested-parallel mixed-methods design with intervention.
Eligibility Criteria
Inclusion Criteria:
diagnosis of breast cancer
chronic CIPN symptoms in one or both lower extremities
three months or greater since last chemotherapy treatment
mean SF-MPQ-2 score of greater than or equal to three
a prognosis of greater than six months
Exclusion Criteria:
non-English-speaking
blindness
pregnancy
breastfeeding
allergy to EOI or Peru balsam (cross-allergen)
illegal substance usage
history of severe skin reactions
non-intact skin on lower extremities
history of lower extremity trauma or amputation
current use of aromatherapy/Essential Oils
asthma or reactive airway disease triggered by constituents of EOI
history of mental illness or chronic depression
the following co-morbidities: G6PD deficiency, inherited peripheral neuropathy, active herpes varicella-zoster, herpes simplex virus, alcoholic neuropathy, repetitive stress or entrapment neuropathy, peripheral vascular disease, and multifocal mononeuropathy.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Augusta Georgia, 30912, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.